Biotech sector sees increased funding for Q1

04/5/2012 | BioWorld Online (free registration)

For the first three months of the year, U.S. biotech venture funding rounds reached $391 million, a 34% increase to figures for the same period last year, according to BioWorld data. The biggest increases came in support of early-stage innovations: Series A and seed deals brought in 63% more funding in the first quarter. The trend suggests the biotech industry could be a healthier environment for investing in 2012.

View Full Article in:

BioWorld Online (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC